Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 292 articles:
HTML format



Single Articles


    January 2022
  1. YU F, Zhou X, Jin X, Zhao S, et al
    Rational construction of controllable autoimmune diabetes model depicting clinical features.
    PLoS One. 2022;17:e0260100.
    PubMed     Abstract available


  2. OKOTH K, Subramanian A, Chandan JS, Adderley NJ, et al
    Long term miscarriage-related hypertension and diabetes mellitus. Evidence from a United Kingdom population-based cohort study.
    PLoS One. 2022;17:e0261769.
    PubMed     Abstract available


  3. ARIF B, Arif Z, Ahmad J, Perveen K, et al
    Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
    PLoS One. 2022;17:e0262233.
    PubMed     Abstract available


  4. KALKOWSKI L, Golubczyk D, Kwiatkowska J, Domzalska M, et al
    Local autoimmune encephalomyelitis model in a rat brain with precise control over lesion placement.
    PLoS One. 2022;17:e0262677.
    PubMed     Abstract available


  5. WIJEYARATNAM DO, Edwards T, Pilutti LA, Cressman EK, et al
    Assessing visually guided reaching in people with multiple sclerosis with and without self-reported upper limb impairment.
    PLoS One. 2022;17:e0262480.
    PubMed     Abstract available


  6. HORTON MK, McCurdy S, Shao X, Bellesis K, et al
    Case-control study of adverse childhood experiences and multiple sclerosis risk and clinical outcomes.
    PLoS One. 2022;17:e0262093.
    PubMed     Abstract available


  7. SARPONG-KUMANKOMAH S, Knox KB, Kelly ME, Hunter G, et al
    Quantification of human plasma metalloproteins in multiple sclerosis, ischemic stroke and healthy controls reveals an association of haptoglobin-hemoglobin complexes with age.
    PLoS One. 2022;17:e0262160.
    PubMed     Abstract available


  8. HODREA J, Saeed A, Molnar A, Fintha A, et al
    SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
    PLoS One. 2022;17:e0263285.
    PubMed     Abstract available


  9. PETROVA T, Bennett K, Nanda S, Strickson S, et al
    Why are the phenotypes of TRAF6 knock-in and TRAF6 knock-out mice so different?
    PLoS One. 2022;17:e0263151.
    PubMed     Abstract available


  10. LERKVALEEKUL B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, et al
    Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
    PLoS One. 2022;17:e0263536.
    PubMed     Abstract available


  11. AL-KAFAJI G, Bakheit HF, AlAli F, Fattah M, et al
    Next-generation sequencing of the whole mitochondrial genome identifies functionally deleterious mutations in patients with multiple sclerosis.
    PLoS One. 2022;17:e0263606.
    PubMed     Abstract available


  12. ALAZWARI A, Abdollahian M, Tafakori L, Johnstone A, et al
    Predicting age at onset of type 1 diabetes in children using regression, artificial neural network and Random Forest: A case study in Saudi Arabia.
    PLoS One. 2022;17:e0264118.
    PubMed     Abstract available


  13. BEDI S, Richardson TM, Jia B, Saab H, et al
    Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.
    PLoS One. 2022;17:e0261103.
    PubMed     Abstract available


  14. TANIGUCHI H, Nirengi S, Ishihara K, Sakane N, et al
    Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0263774.
    PubMed     Abstract available


  15. QUIGLEY M, Earnest A, Szwarcbard N, Wischer N, et al
    Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.
    PLoS One. 2022;17:e0263511.
    PubMed     Abstract available


  16. LI JY, Sun XH, Shen DC, Yang XZ, et al
    Clinical characteristics and prognosis of amyotrophic lateral sclerosis with autoimmune diseases.
    PLoS One. 2022;17:e0266529.
    PubMed     Abstract available


  17. MEKONNEN GA, Gelaye KA, Gebreyohannes EA, Abegaz TM, et al
    Treatment outcomes of diabetic ketoacidosis among diabetes patients in Ethiopia. Hospital-based study.
    PLoS One. 2022;17:e0264626.
    PubMed     Abstract available


  18. KONG X, Diao S, Xu H, Sun J, et al
    Association between miRNA-499 gene polymorphism and autoimmune diseases: A meta-analysis.
    PLoS One. 2022;17:e0266265.
    PubMed     Abstract available


  19. MIKKELSEN AP, Egerup P, Kolte AM, Westergaard D, et al
    Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study.
    PLoS One. 2022;17:e0266203.
    PubMed     Abstract available


  20. QEADAN F, Tingey B, Egbert J, Pezzolesi MG, et al
    The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data.
    PLoS One. 2022;17:e0266809.
    PubMed     Abstract available


  21. MIRMOSAYYEB O, Ebrahimi N, Barzegar M, Afshari-Safavi A, et al
    Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.
    PLoS One. 2022;17:e0266492.
    PubMed     Abstract available


  22. CHEN X, Zhang Y, Luo Z, Wu Y, et al
    Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0264705.
    PubMed     Abstract available


  23. TANA MM, Klepper A, Lyden A, Pisco AO, et al
    Transcriptomic profiling of blood from autoimmune hepatitis patients reveals potential mechanisms with implications for management.
    PLoS One. 2022;17:e0264307.
    PubMed     Abstract available


  24. NGAMJANYAPORN P, Worawichawong S, Pisitkun P, Khiewngam K, et al
    Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    PLoS One. 2022;17:e0263778.
    PubMed     Abstract available


  25. CORTESI PA, Antonazzo IC, Gasperini C, Nica M, et al
    Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy.
    PLoS One. 2022;17:e0264123.
    PubMed     Abstract available


  26. KOKAS Z, Sandi D, Fricska-Nagy Z, Fuvesi J, et al
    Do Hungarian multiple sclerosis care units fulfil international criteria?
    PLoS One. 2022;17:e0264328.
    PubMed     Abstract available


  27. YADAV M, Ali S, Shrode RL, Shahi SK, et al
    Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
    PLoS One. 2022;17:e0264556.
    PubMed     Abstract available


  28. BIERNACKI T, Sandi D, Fuvesi J, Fricska-Nagy Z, et al
    The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
    PLoS One. 2022;17:e0267346.
    PubMed     Abstract available


  29. ROVO A, Cantoni N, Samii K, Rufer A, et al
    Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
    PLoS One. 2022;17:e0267342.
    PubMed     Abstract available


  30. FICHTNER ML, Hoarty MD, Vadysirisack DD, Munro-Sheldon B, et al
    Myasthenia gravis complement activity is independent of autoantibody titer and disease severity.
    PLoS One. 2022;17:e0264489.
    PubMed     Abstract available


  31. ZRUBKA Z, Kincses A, Ferenci T, Kovacs L, et al
    Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.
    PLoS One. 2022;17:e0264708.
    PubMed     Abstract available


  32. LIN X, Liu Y, Chen Y, Huang X, et al
    Prediction of prognosis in immunoglobulin a nephropathy patients with focal crescent by machine learning.
    PLoS One. 2022;17:e0265017.
    PubMed     Abstract available


  33. SHOBEIRI P, Karimi A, Momtazmanesh S, Teixeira AL, et al
    Exercise-induced increase in blood-based brain-derived neurotrophic factor (BDNF) in people with multiple sclerosis: A systematic review and meta-analysis of exercise intervention trials.
    PLoS One. 2022;17:e0264557.
    PubMed     Abstract available


  34. GIOVANNETTI AM, Pakenham KI, Presti G, Quartuccio ME, et al
    A group resilience training program for people with multiple sclerosis: Study protocol of a multi-centre cluster-randomized controlled trial (multi-READY for MS).
    PLoS One. 2022;17:e0267245.
    PubMed     Abstract available


  35. RAHIM T, Levinson MA, Carufe KEW, Burak M, et al
    The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.
    PLoS One. 2022;17:e0267913.
    PubMed     Abstract available


  36. ROMERO-PINEL L, Bau L, Matas E, Leon I, et al
    Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator.
    PLoS One. 2022;17:e0267504.
    PubMed     Abstract available


  37. WILSON-MENZFELD G, Naisby J, Baker K, Morris R, et al
    Yoga provision for individuals living with Multiple Sclerosis: Is the future online?
    PLoS One. 2022;17:e0266786.
    PubMed     Abstract available


  38. HIERL KV, Krause M, Kruber D, Sterker I, et al
    3-D cephalometry of the the orbit regarding endocrine orbitopathy, exophthalmos, and sex.
    PLoS One. 2022;17:e0265324.
    PubMed     Abstract available


  39. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    PubMed     Abstract available


  40. IIDA M, Ohtomo S, Wada NA, Ueda O, et al
    TNF-alpha induces Claudin-1 expression in renal tubules in Alport mice.
    PLoS One. 2022;17:e0265081.
    PubMed     Abstract available


  41. BOIS A, Tervil B, Moreau A, Vienne-Jumeau A, et al
    A topological data analysis-based method for gait signals with an application to the study of multiple sclerosis.
    PLoS One. 2022;17:e0268475.
    PubMed     Abstract available


  42. ALVAREZ-RODRIGUEZ E, Sanchez-Franco CM, Perez-Haro MJ, Bello-Otero L, et al
    Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients.
    PLoS One. 2022;17:e0268125.
    PubMed     Abstract available


  43. KIBIRIGE D, Sekitoleko I, Balungi P, Kyosiimire-Lugemwa J, et al
    Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.
    PLoS One. 2022;17:e0268783.
    PubMed     Abstract available


  44. SHEU NW, Huang SH, Wu DC, Kao JY, et al
    Effects of Helicobacter pylori treatment on the incidences of autoimmune diseases and inflammatory bowel disease in patients with diabetes mellitus.
    PLoS One. 2022;17:e0265323.
    PubMed     Abstract available


  45. COYNE MJ, Schultze AE, McCrann DJ 3rd, Murphy RE, et al
    Evaluation of renal injury and function biomarkers, including symmetric dimethylarginine (SDMA), in the rat passive Heymann nephritis (PHN) model.
    PLoS One. 2022;17:e0269085.
    PubMed     Abstract available


  46. ELKHALII-WILHELM S, Sippel A, Riemann-Lorenz K, Kofahl C, et al
    Experiences of persons with Multiple Sclerosis with lifestyle adjustment-A qualitative interview study.
    PLoS One. 2022;17:e0268988.
    PubMed     Abstract available


  47. KOFFMAN J, Penfold C, Cottrell L, Farsides B, et al
    "I wanna live and not think about the future" what place for advance care planning for people living with severe multiple sclerosis and their families? A qualitative study.
    PLoS One. 2022;17:e0265861.
    PubMed     Abstract available


  48. YOKOMICHI H, Mochizuki M, Shinohara R, Kushima M, et al
    Gestational age, birth weight, and perinatal complications in mothers with diabetes and impaired glucose tolerance: Japan Environment and Children's Study cohort.
    PLoS One. 2022;17:e0269610.
    PubMed     Abstract available


  49. ALLY N, Alli HD, Jeeva-Patel T, Mochan A, et al
    Optic neuritis: A South African hospital-based prospective study protocol.
    PLoS One. 2022;17:e0269514.
    PubMed     Abstract available


  50. HILLS SL, Soeung SC, Sarath S, Morn C, et al
    An evaluation of adverse events following an immunization campaign with the live, attenuated SA14-14-2 Japanese encephalitis vaccine in Cambodia.
    PLoS One. 2022;17:e0269480.
    PubMed     Abstract available


  51. MAROZOFF S, Mai A, Dehghan N, Sayre EC, et al
    Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: A population-based study.
    PLoS One. 2022;17:e0270142.
    PubMed     Abstract available


  52. HUANG Y, Wang WK, Zheng XM, Yang L, et al
    Decreased salivary alpha-amylase activity responding to citric acid stimulation in Myasthenia gravis with malnutrition.
    PLoS One. 2022;17:e0269621.
    PubMed     Abstract available


    January 2021
  53. ZUCCHI D, Tani C, Elefante E, Stagnaro C, et al
    Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
    PLoS One. 2021;16:e0245274.
    PubMed     Abstract available


  54. RUIZ-QUINONEZ JA, Guzman-Priego CG, Nolasco-Rosales GA, Tovilla-Zarate CA, et al
    Features of patients that died for COVID-19 in a hospital in the south of Mexico: A observational cohort study.
    PLoS One. 2021;16:e0245394.
    PubMed     Abstract available


  55. JOHNSON DK, Reynolds KM, Poole BD, Montierth MD, et al
    Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    PLoS One. 2021;16:e0243150.
    PubMed     Abstract available


  56. KATEWA A, Suto E, Hui J, Heredia J, et al
    The peptide symporter SLC15a4 is essential for the development of systemic lupus erythematosus in murine models.
    PLoS One. 2021;16:e0244439.
    PubMed     Abstract available


  57. WILLETT K, Khan RS, Dine K, Wessel H, et al
    Neuroprotection mediated by ST266 requires full complement of proteins secreted by amnion-derived multipotent progenitor cells.
    PLoS One. 2021;16:e0243862.
    PubMed     Abstract available


  58. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available


  59. KLISTORNER S, Barnett MH, Wasserthal J, Yiannikas C, et al
    Differentiating axonal loss and demyelination in chronic MS lesions: A novel approach using single streamline diffusivity analysis.
    PLoS One. 2021;16:e0244766.
    PubMed     Abstract available


  60. ALEXANDRE K, Vallet F, Peytremann-Bridevaux I, Desrichard O, et al
    Identification of diabetes self-management profiles in adults: A cluster analysis using selected self-reported outcomes.
    PLoS One. 2021;16:e0245721.
    PubMed     Abstract available


  61. SUBEKTI I, Kartiko GJ, Suhardi ZF, Muhadi, et al
    Serum TSH level as predictor of Graves' disease recurrence following antithyroid drug withdrawal: A systematic review.
    PLoS One. 2021;16:e0245978.
    PubMed     Abstract available


  62. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
    Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
    PLoS One. 2021;16:e0245869.
    PubMed     Abstract available


  63. THALER C, Kyselyova AA, Faizy TD, Nawka MT, et al
    Heterogeneity of multiple sclerosis lesions in fast diffusional kurtosis imaging.
    PLoS One. 2021;16:e0245844.
    PubMed     Abstract available


  64. LAPARIDOU D, Curtis F, Akanuwe J, Jackson J, et al
    Patients' experiences and perceptions of Guillain-Barre syndrome: A systematic review and meta-synthesis of qualitative research.
    PLoS One. 2021;16:e0245826.
    PubMed     Abstract available


  65. BSTEH G, Assar H, Hegen H, Heschl B, et al
    COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry.
    PLoS One. 2021;16:e0255316.
    PubMed     Abstract available


  66. AVARI P, Unsworth R, Rilstone S, Uduku C, et al
    Improved glycaemia during the Covid-19 pandemic lockdown is sustained post-lockdown and during the "Eat Out to Help Out" Government Scheme, in adults with Type 1 diabetes in the United Kingdom.
    PLoS One. 2021;16:e0254951.
    PubMed     Abstract available


  67. GOODIN DS, Khankhanian P, Gourraud PA, Vince N, et al
    The nature of genetic and environmental susceptibility to multiple sclerosis.
    PLoS One. 2021;16:e0246157.
    PubMed     Abstract available


  68. WASEDA Y, Yamada K, Mizuguchi K, Ito K, et al
    The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease.
    PLoS One. 2021;16:e0247173.
    PubMed     Abstract available


  69. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    PubMed     Abstract available


  70. HE J, Kong D, Yang Z, Guo R, et al
    Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.
    PLoS One. 2021;16:e0247662.
    PubMed     Abstract available


  71. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available


  72. HAMED SA, Attiah FA, Abdulhamid SK, Fawzy M, et al
    Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
    PLoS One. 2021;16:e0248937.
    PubMed     Abstract available


  73. GOUJON A, Mirafzal S, Zuber K, Deschamps R, et al
    3D-Fast Gray Matter Acquisition with Phase Sensitive Inversion Recovery Magnetic Resonance Imaging at 3 Tesla: Application for detection of spinal cord lesions in patients with multiple sclerosis.
    PLoS One. 2021;16:e0247813.
    PubMed     Abstract available


  74. GAWRECKI A, Zozulinska-Ziolkiewicz D, Michalak MA, Adamska A, et al
    Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes.
    PLoS One. 2021;16:e0248965.
    PubMed     Abstract available


  75. WITTENBORN TR, Fahlquist Hagert C, Ferapontov A, Fonager S, et al
    Comparison of gamma and x-ray irradiation for myeloablation and establishment of normal and autoimmune syngeneic bone marrow chimeras.
    PLoS One. 2021;16:e0247501.
    PubMed     Abstract available


  76. KIM SE, Kim J, Lee JY, Lee SB, et al
    Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-kappaB pathway.
    PLoS One. 2021;16:e0249988.
    PubMed     Abstract available


  77. DIRNENA-FUSINI I, Am MK, Fougner AL, Carlsen SM, et al
    Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0249611.
    PubMed     Abstract available


  78. MOHD R, Mohammad Kazmin NE, Abdul Cader R, Abd Shukor N, et al
    Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
    PLoS One. 2021;16:e0249592.
    PubMed     Abstract available


  79. PRIDHAM G, Hossain S, Rawji KS, Zhang Y, et al
    A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    PLoS One. 2021;16:e0249460.
    PubMed     Abstract available


  80. ROLDAN CA, Sibbitt WL Jr, Greene ER, Qualls CR, et al
    Libman-Sacks endocarditis and associated cerebrovascular disease: The role of medical therapy.
    PLoS One. 2021;16:e0247052.
    PubMed     Abstract available


  81. CHOI S, Spini M, Hua J, Harrison DM, et al
    Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE DeltaT1 mapping.
    PLoS One. 2021;16:e0249973.
    PubMed     Abstract available


  82. LUU T, Cheung JF, Baccon J, Waldner H, et al
    Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2021;16:e0250340.
    PubMed     Abstract available


  83. SAKUNRANGSIT N, Metheepakornchai P, Kumpunya S, Greenblatt MB, et al
    Etanercept prevents TNF-alpha mediated mandibular bone loss in FcgammaRIIb-/- lupus model.
    PLoS One. 2021;16:e0250215.
    PubMed     Abstract available


  84. LIU GY, Wu Y, Kong FY, Ma S, et al
    BMSCs differentiated into neurons, astrocytes and oligodendrocytes alleviated the inflammation and demyelination of EAE mice models.
    PLoS One. 2021;16:e0243014.
    PubMed     Abstract available


  85. SATITPITAKUL V, Rattanaphong T, Pruksakorn V
    Meibomian glands dropout in patients with inactive thyroid related orbitopathy.
    PLoS One. 2021;16:e0250617.
    PubMed     Abstract available


  86. STERNBACH S, West N, Singhal NK, Clements R, et al
    The BHMT-betaine methylation pathway epigenetically modulates oligodendrocyte maturation.
    PLoS One. 2021;16:e0250486.
    PubMed     Abstract available


  87. GOLAN D, Sagiv S, Glass-Marmor L, Miller A, et al
    Mobile-phone-based e-diary derived patient reported outcomes: Association with clinical disease activity, psychological status and quality of life of patients with multiple sclerosis.
    PLoS One. 2021;16:e0250647.
    PubMed     Abstract available


  88. ALKHATEEB H, El Fathi A, Ghanbari M, Haidar A, et al
    Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.
    PLoS One. 2021;16:e0248280.
    PubMed     Abstract available


  89. SENDIC S, Mansouri L, Lundberg S, Nopp A, et al
    B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.
    PLoS One. 2021;16:e0248056.
    PubMed     Abstract available


  90. SHAHARIR SS, Chua SH, Mohd R, Mustafar R, et al
    Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
    PLoS One. 2021;16:e0248845.
    PubMed     Abstract available


  91. CANDADAI AA, Liu F, Fouda AY, Alfarhan M, et al
    Deletion of arginase 2 attenuates neuroinflammation in an experimental model of optic neuritis.
    PLoS One. 2021;16:e0247901.
    PubMed     Abstract available


  92. IBRAHIM N, Treluyer JM, Briand N, Godot C, et al
    Text message reminders for adolescents with poorly controlled type 1 diabetes: A randomized controlled trial.
    PLoS One. 2021;16:e0248549.
    PubMed     Abstract available


  93. WILSKI M, Brola W, Luniewska M, Tomczak M, et al
    The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies.
    PLoS One. 2021;16:e0248135.
    PubMed     Abstract available


  94. SATO H, Ichikawa D, Okada E, Suzuki T, et al
    Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy.
    PLoS One. 2021;16:e0251294.
    PubMed     Abstract available


  95. LU Z, Liu W, Gao H, Chen W, et al
    Traditional Chinese Medicine as an adjunct therapy in the treatment of idiopathic membranous nephropathy: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251131.
    PubMed     Abstract available


  96. FATOYE F, Gebrye T, Svenson LW
    Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    PLoS One. 2021;16:e0251409.
    PubMed     Abstract available


  97. LIAO K, Chen K, Brett S, Gehman A, et al
    Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study.
    PLoS One. 2021;16:e0249049.
    PubMed     Abstract available


  98. CHARNIGA K, Cucunuba ZM, Walteros DM, Mercado M, et al
    Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017.
    PLoS One. 2021;16:e0252236.
    PubMed     Abstract available


  99. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    PubMed     Abstract available


  100. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed     Abstract available


  101. STOUGAARD EB, Winther SA, Amadid H, Frimodt-Moller M, et al
    Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
    PLoS One. 2021;16:e0254859.
    PubMed     Abstract available


  102. MECA-LALLANA JE, Maurino J, Perez-Miralles F, Forero L, et al
    Quantifying the patient s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire.
    PLoS One. 2021;16:e0255317.
    PubMed     Abstract available


  103. NEGASH Z, Berha AB, Shibeshi W, Ahmed A, et al
    Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0251709.
    PubMed     Abstract available


  104. HOFFMAN WH, Whelan SA, Lee N
    Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
    PLoS One. 2021;16:e0254116.
    PubMed     Abstract available


  105. SANTISTEBAN L, Teremetz M, Irazusta J, Lindberg PG, et al
    Outcome measures used in trials on gait rehabilitation in multiple sclerosis: A systematic literature review.
    PLoS One. 2021;16:e0257809.
    PubMed     Abstract available


  106. SWANN JW, Tayler S, Hall H, Sparrow R, et al
    Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom.
    PLoS One. 2021;16:e0257700.
    PubMed     Abstract available


  107. MCCALL JL, Blair HC, Blethen KE, Hall C, et al
    Prenatal cadmium exposure does not induce greater incidence or earlier onset of autoimmunity in the offspring.
    PLoS One. 2021;16:e0249442.
    PubMed     Abstract available


  108. GAJ S, Ontaneda D, Nakamura K
    Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI.
    PLoS One. 2021;16:e0255939.
    PubMed     Abstract available


  109. KIRILMAZ OB, Salegaonkar AR, Shiau J, Uzun G, et al
    Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system.
    PLoS One. 2021;16:e0254718.
    PubMed     Abstract available


  110. AHN SS, Yoon T, Song JJ, Park YB, et al
    Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis.
    PLoS One. 2021;16:e0254226.
    PubMed     Abstract available


  111. JOHNSON M, Ehlers S, Fernell E, Hajjari P, et al
    Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review.
    PLoS One. 2021;16:e0253844.
    PubMed     Abstract available


  112. BRATT G, Brannstrom J, Missalidis C, Nystrom T, et al
    Development of type 2 diabetes and insulin resistance in people with HIV infection: Prevalence, incidence and associated factors.
    PLoS One. 2021;16:e0254079.
    PubMed     Abstract available


  113. NGUYEN THP, Fagerland MW, Deyab G, Hjeltnes G, et al
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis.
    PLoS One. 2021;16:e0253793.
    PubMed     Abstract available


  114. FAGBAMIGBE AF, Norrman E, Bergh C, Wennerholm UB, et al
    Comparison of the performances of survival analysis regression models for analysis of conception modes and risk of type-1 diabetes among 1985-2015 Swedish birth cohort.
    PLoS One. 2021;16:e0253389.
    PubMed     Abstract available


  115. VAN DOORN WPTM, Foreman YD, Schaper NC, Savelberg HHCM, et al
    Machine learning-based glucose prediction with use of continuous glucose and physical activity monitoring data: The Maastricht Study.
    PLoS One. 2021;16:e0253125.
    PubMed     Abstract available


  116. VERES G, Vas NF, Lyngby Lassen M, Beresova M, et al
    Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups.
    PLoS One. 2021;16:e0253419.
    PubMed     Abstract available


  117. ROGACZEWSKA M, Michalak S, Stopa M
    Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: An optical coherence tomography angiography study.
    PLoS One. 2021;16:e0253417.
    PubMed     Abstract available


  118. WYSOCKA-MINCEWICZ M, Golebiewska J, Baszynska-Wilk M, Olechowski A, et al
    Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes.
    PLoS One. 2021;16:e0252588.
    PubMed     Abstract available


  119. WORAWICHAWONG S, Plumworasawat S, Liwlompaisan W, Sumethkul V, et al
    Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy.
    PLoS One. 2021;16:e0252638.
    PubMed     Abstract available


  120. PAPP V, Buron MD, Siersma V, Rasmussen PV, et al
    Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.
    PLoS One. 2021;16:e0250820.
    PubMed     Abstract available


  121. ROZYCKA J
    How I see is how I feel. Identification of illness perception schema and its association with adaptation outcomes in multiple sclerosis - a 5-year prospective study.
    PLoS One. 2021;16:e0258740.
    PubMed     Abstract available


  122. PARIKH RV, Tan TC, Fan D, Law D, et al
    Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    PLoS One. 2021;16:e0257674.
    PubMed     Abstract available


  123. MOCCIA M, Affinito G, Capacchione A, Lanzillo R, et al
    Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data.
    PLoS One. 2021;16:e0258017.
    PubMed     Abstract available


  124. NG KEE KWONG KC, Mollison D, Meijboom R, York EN, et al
    The prevalence of paramagnetic rim lesions in multiple sclerosis: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0256845.
    PubMed     Abstract available


  125. SERAJI M, Mohebbi M, Safari A, Krekelberg B, et al
    Multiple sclerosis reduces synchrony of the magnocellular pathway.
    PLoS One. 2021;16:e0255324.
    PubMed     Abstract available


  126. JANG SY, Choi SH, Kikkawa D, Lee EJ, et al
    Association of fibroblast growth factor 10 with the fibrotic and inflammatory pathogenesis of Graves' orbitopathy.
    PLoS One. 2021;16:e0255344.
    PubMed     Abstract available


  127. GOODIN DS, Oksenberg JR, Douillard V, Gourraud PA, et al
    Genetic susceptibility to multiple sclerosis in African Americans.
    PLoS One. 2021;16:e0254945.
    PubMed     Abstract available


  128. SIDDIG O, Mustafa MB, Kordofani Y, Gibson J, et al
    The epidemiology of autoimmune bullous diseases in Sudan between 2000 and 2016.
    PLoS One. 2021;16:e0254634.
    PubMed     Abstract available


  129. MECA-LALLANA JE, Oreja-Guevara C, Munoz D, Olascoaga J, et al
    Four-year safety and effectiveness data from patients with multiple sclerosis treated with fingolimod: The Spanish GILENYA registry.
    PLoS One. 2021;16:e0258437.
    PubMed     Abstract available


  130. TEZUKA Y, Eguchi-Ishimae M, Ozaki E, Ito T, et al
    Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
    PLoS One. 2021;16:e0258090.
    PubMed     Abstract available


  131. LIONAKI S, Makropoulos I, Panagiotellis K, Vlachopanos G, et al
    Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
    PLoS One. 2021;16:e0253337.
    PubMed     Abstract available


  132. MARTIN-MARQUEZ BT, Satoh M, Hernandez-Pando R, Martinez-Garcia EA, et al
    The DNA co-vaccination using Sm antigen and IL-10 as prophylactic experimental therapy ameliorates nephritis in a model of lupus induced by pristane.
    PLoS One. 2021;16:e0259114.
    PubMed     Abstract available


  133. KIM SS, Hudgins AD, Yang J, Zhu Y, et al
    A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation.
    PLoS One. 2021;16:e0257265.
    PubMed     Abstract available


  134. OSAKI T, Souri M, Ichinose A
    Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis.
    PLoS One. 2021;16:e0257322.
    PubMed     Abstract available


  135. AHMAD I, Wergeland S, Oveland E, Bo L, et al
    A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.
    PLoS One. 2021;16:e0256155.
    PubMed     Abstract available


  136. NATHAN DM, Krause-Steinrauf H, Braffett BH, Arends VL, et al
    Comparison of central laboratory HbA1c measurements obtained from a capillary collection versus a standard venous whole blood collection in the GRADE and EDIC studies.
    PLoS One. 2021;16:e0257154.
    PubMed     Abstract available


  137. KRUGER K, Fricke LM, Dilger EM, Thiele A, et al
    How is and how should healthcare for people with multiple sclerosis in Germany be designed?-The rationale and protocol for the mixed-methods study Multiple Sclerosis-Patient-Oriented Care in Lower Saxony (MS-PoV).
    PLoS One. 2021;16:e0259855.
    PubMed     Abstract available


  138. ALKETBI A, Basit S, Hamza N, Walton LM, et al
    The added value of cognition-targeted exercise versus symptom-targeted exercise for multiple sclerosis fatigue: A randomized controlled pilot trial.
    PLoS One. 2021;16:e0258752.
    PubMed     Abstract available


  139. PARUNYAKUL K, Srisuksai K, Charoenlappanit S, Phaonakrop N, et al
    Metabolic impacts of cordycepin on hepatic proteomic expression in streptozotocin-induced type 1 diabetic mice.
    PLoS One. 2021;16:e0256140.
    PubMed     Abstract available


  140. SAPOSNIK G, Del Rio B, Bueno-Gil G, Sempere AP, et al
    Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain.
    PLoS One. 2021;16:e0261050.
    PubMed     Abstract available


  141. VALORI M, Jansson L, Tienari PJ
    CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies.
    PLoS One. 2021;16:e0261002.
    PubMed     Abstract available


  142. ZANGENEH Z, Abdi-Ali A, Khamooshian K, Alvandi A, et al
    Bacterial variation in the oral microbiota in multiple sclerosis patients.
    PLoS One. 2021;16:e0260384.
    PubMed     Abstract available


  143. RENAUD A, Caristan A, Seguin A, Agard C, et al
    Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura.
    PLoS One. 2021;16:e0260196.
    PubMed     Abstract available


  144. BOCH K, Drager S, Zillikens D, Hudemann C, et al
    Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.
    PLoS One. 2021;16:e0259586.
    PubMed     Abstract available


  145. HSU CY, Chueh YS, Kuo ML, Lee PT, et al
    Expansion of invariant natural killer T cells from systemic lupus erythematosus patients by alpha-Galactosylceramide and IL-15.
    PLoS One. 2021;16:e0261727.
    PubMed     Abstract available


  146. BLUTHGEN C, Patella M, Euler A, Baessler B, et al
    Computed tomography radiomics for the prediction of thymic epithelial tumor histology, TNM stage and myasthenia gravis.
    PLoS One. 2021;16:e0261401.
    PubMed     Abstract available


  147. COOLEN M, Broadley M, Hendrieckx C, Chatwin H, et al
    The impact of hypoglycemia on quality of life and related outcomes in children and adolescents with type 1 diabetes: A systematic review.
    PLoS One. 2021;16:e0260896.
    PubMed     Abstract available


  148. MIMPEN M, Rolf L, Poelmans G, van den Ouweland J, et al
    Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis.
    PLoS One. 2021;16:e0261097.
    PubMed     Abstract available


  149. MANUWALD U, Schoffer O, Kugler J, Riemenschneider H, et al
    Trends in incidence and prevalence of type 1 diabetes between 1999 and 2019 based on the Childhood Diabetes Registry of Saxony, Germany.
    PLoS One. 2021;16:e0262171.
    PubMed     Abstract available


  150. CAREY IM, Banchoff E, Nirmalananthan N, Harris T, et al
    Prevalence and incidence of neuromuscular conditions in the UK between 2000 and 2019: A retrospective study using primary care data.
    PLoS One. 2021;16:e0261983.
    PubMed     Abstract available


  151. MIDTHASSEL TC, Hansen AH
    Are lifestyle changes from online information associated with discussing the information with a doctor? A cross -sectional study.
    PLoS One. 2021;16:e0261471.
    PubMed     Abstract available


    January 2020
  152. LI Z, Rotival M, Patin E, Michel F, et al
    Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
    PLoS One. 2020;15:e0225289.
    PubMed     Abstract available


  153. MATSUOKA N, Fujita Y, Temmoku J, Furuya MY, et al
    Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
    PLoS One. 2020;15:e0227069.
    PubMed     Abstract available


  154. JANG S, Kim JH, Choi SY, Park SJ, et al
    Application of computerized 3D-CT texture analysis of pancreas for the assessment of patients with diabetes.
    PLoS One. 2020;15:e0227492.
    PubMed     Abstract available


  155. PLAZINSKA MT, Sawicka-Gutaj N, Czarnywojtek A, Wolinski K, et al
    Radioiodine therapy and Graves' disease - Myths and reality.
    PLoS One. 2020;15:e0226495.
    PubMed     Abstract available


  156. OGAWA-AKIYAMA A, Sugiyama H, Kitagawa M, Tanaka K, et al
    Podocyte autophagy is associated with foot process effacement and proteinuria in patients with minimal change nephrotic syndrome.
    PLoS One. 2020;15:e0228337.
    PubMed     Abstract available


  157. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
    Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
    PLoS One. 2020;15:e0227479.
    PubMed     Abstract available


  158. AHMED CM, Ildefonso CJ, Johnson HM, Lewin AS, et al
    A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis.
    PLoS One. 2020;15:e0227524.
    PubMed     Abstract available


  159. CHEWCHARAT A, Chewcharat P, Rutirapong A, Papatheodorou S, et al
    The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.
    PLoS One. 2020;15:e0228315.
    PubMed     Abstract available


  160. PELLEGRINO M, Traversi G, Arena A, Cappa M, et al
    Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients.
    PLoS One. 2020;15:e0228296.
    PubMed     Abstract available


  161. PENG YH, Lin YS, Chen CH, Tsai KY, et al
    Type 1 diabetes is associated with an increased risk of venous thromboembolism: A retrospective population-based cohort study.
    PLoS One. 2020;15:e0226997.
    PubMed     Abstract available


  162. HOSONUMA M, Yajima N, Takahashi R, Yanai R, et al
    Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity.
    PLoS One. 2020;15:e0227022.
    PubMed     Abstract available


  163. GOUGH N, Brkan L, Subramaniam P, Chiuccariello L, et al
    Feasibility of remotely supervised transcranial direct current stimulation and cognitive remediation: A systematic review.
    PLoS One. 2020;15:e0223029.
    PubMed     Abstract available


  164. GOLDMAN MD, Dwyer L, Coleman R, Sohn MW, et al
    Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.
    PLoS One. 2020;15:e0228617.
    PubMed     Abstract available


  165. HJORTH M, Dandu N, Mellergard J
    Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
    PLoS One. 2020;15:e0228380.
    PubMed     Abstract available


  166. GRANER M, Pointon T, Manton S, Green M, et al
    Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
    PLoS One. 2020;15:e0228883.
    PubMed     Abstract available


  167. ZWINGLI G, Yerly J, Mivelaz Y, Stoppa-Vaucher S, et al
    Non-invasive assessment of coronary endothelial function in children and adolescents with type 1 diabetes mellitus using isometric handgrip exercise-MRI: A feasibility study.
    PLoS One. 2020;15:e0228569.
    PubMed     Abstract available


  168. GIOVANNETTI AM, Pietrolongo E, Borreani C, Giordano A, et al
    Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy.
    PLoS One. 2020;15:e0228587.
    PubMed     Abstract available


  169. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed     Abstract available


  170. AUNGSUMART S, Apiwattanakul M
    Cost effectiveness of rituximab and mycophenolate mofetil for neuromyelitis optica spectrum disorder in Thailand: Economic evaluation and budget impact analysis.
    PLoS One. 2020;15:e0229028.
    PubMed     Abstract available


  171. YALACHKOV Y, Uhlmann V, Bergmann J, Soydas D, et al
    Patients with chronic autoimmune demyelinating polyneuropathies exhibit cognitive deficits which might be associated with CSF evidence of blood-brain barrier disturbance.
    PLoS One. 2020;15:e0228679.
    PubMed     Abstract available


  172. BRANT EJ, Rietman EA, Klement GL, Cavaglia M, et al
    Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks.
    PLoS One. 2020;15:e0226883.
    PubMed     Abstract available


  173. EVERS J, Grotenhuis AJ, Aben KKH, Kiemeney LALM, et al
    No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
    PLoS One. 2020;15:e0229384.
    PubMed     Abstract available


  174. SAGAR D, Gaddipati R, Ongstad EL, Bhagroo N, et al
    LOX-1: A potential driver of cardiovascular risk in SLE patients.
    PLoS One. 2020;15:e0229184.
    PubMed     Abstract available


  175. JULIAN GS, Rosim RP, Carneseca EC, Rigolon J, et al
    Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.
    PLoS One. 2020;15:e0229768.
    PubMed     Abstract available


  176. GONGORA-RIVERA F, Grijalva I, Infante-Valenzuela A, Camara-Lemarroy C, et al
    Zika Virus infection and Guillain-Barre syndrome in Northeastern Mexico: A case-control study.
    PLoS One. 2020;15:e0230132.
    PubMed     Abstract available


  177. RAMESH J, Parthasarathy LK, Janckila AJ, Begum F, et al
    Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia.
    PLoS One. 2020;15:e0230052.
    PubMed     Abstract available


  178. MASTRACCI TL, Colvin SC, Padgett LR, Mirmira RG, et al
    Hypusinated eIF5A is expressed in the pancreas and spleen of individuals with type 1 and type 2 diabetes.
    PLoS One. 2020;15:e0230627.
    PubMed     Abstract available


  179. SECCIA R, Gammelli D, Dominici F, Romano S, et al
    Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis.
    PLoS One. 2020;15:e0230219.
    PubMed     Abstract available


  180. NOWLING TK, Rodgers J, Thiyagarajan T, Wolf B, et al
    Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
    PLoS One. 2020;15:e0230499.
    PubMed     Abstract available


  181. MORIKAWA M, Kato-Hirayama E, Mayama M, Saito Y, et al
    Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy.
    PLoS One. 2020;15:e0230488.
    PubMed     Abstract available


  182. SELGRADE BP, Meyer D, Sosnoff JJ, Franz JR, et al
    Can optical flow perturbations detect walking balance impairment in people with multiple sclerosis?
    PLoS One. 2020;15:e0230202.
    PubMed     Abstract available


  183. SILVA T, Fragoso YD, Destro Rodrigues MFS, Gomes AO, et al
    Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis - Randomized clinical trial.
    PLoS One. 2020;15:e0230551.
    PubMed     Abstract available


  184. MASUDA H, Mori M, Uzawa A, Uchida T, et al
    Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis.
    PLoS One. 2020;15:e0224419.
    PubMed     Abstract available


  185. FOOLAD F, Khodagholi F, Nabavi SM, Javan M, et al
    Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities.
    PLoS One. 2020;15:e0230691.
    PubMed     Abstract available


  186. SAURI-SUAREZ S, Quinones-Aguilar S, Contreras-Marin A, Ramiro-Guerrero EO, et al
    Adherence to self-administering interferon-beta1a using RebiSmart(R) device in Mexican patients with relapsing multiple sclerosis.
    PLoS One. 2020;15:e0230959.
    PubMed     Abstract available


  187. POLSKY S, Garcetti R, Pyle L, Joshee P, et al
    Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study.
    PLoS One. 2020;15:e0230476.
    PubMed     Abstract available


  188. GIOVANNETTI AM, Quintas R, Tramacere I, Giordano A, et al
    A resilience group training program for people with multiple sclerosis: Results of a pilot single-blind randomized controlled trial and nested qualitative study.
    PLoS One. 2020;15:e0231380.
    PubMed     Abstract available


  189. HASHEMI R, Hosseini-Asl SS, Arefhosseini SR, Morshedi M, et al
    The impact of vitamin D3 intake on inflammatory markers in multiple sclerosis patients and their first-degree relatives.
    PLoS One. 2020;15:e0231145.
    PubMed     Abstract available


  190. NINOU I, Sevastou I, Magkrioti C, Kaffe E, et al
    Genetic deletion of Autotaxin from CD11b+ cells decreases the severity of experimental autoimmune encephalomyelitis.
    PLoS One. 2020;15:e0226050.
    PubMed     Abstract available


  191. PARRAVICINI C, Lecca D, Marangon D, Coppolino GT, et al
    Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis.
    PLoS One. 2020;15:e0231483.
    PubMed     Abstract available


  192. ZHANG X, Liu L, Ma X, Hu W, et al
    Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE.
    PLoS One. 2020;15:e0231622.
    PubMed     Abstract available


  193. MANNERING N, Hansen DL, Frederiksen H
    Evans syndrome in children below 13 years of age - A nationwide population-based cohort study.
    PLoS One. 2020;15:e0231284.
    PubMed     Abstract available


  194. AKAISHI T, Takahashi T, Fujihara K, Misu T, et al
    Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
    PLoS One. 2020;15:e0231225.
    PubMed     Abstract available


  195. GORDON RA, Tilstra JS, Marinov A, Nickerson KM, et al
    Murine lupus is neutrophil elastase-independent in the MRL.Faslpr model.
    PLoS One. 2020;15:e0226396.
    PubMed     Abstract available


  196. BARRERO F, Mallada-Frechin J, Martinez-Gines ML, Marzo ME, et al
    Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
    PLoS One. 2020;15:e0230846.
    PubMed     Abstract available


  197. OHLMEIER C, Gothe H, Haas J, Osowski U, et al
    Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
    PLoS One. 2020;15:e0231846.
    PubMed     Abstract available


  198. SUGIYAMA M, Wada Y, Kanazawa N, Tachibana S, et al
    A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schonlein purpura nephritis and IgA nephropathy.
    PLoS One. 2020;15:e0232194.
    PubMed     Abstract available


  199. GOITIA B, Bruno D, Abrevaya S, Sedeno L, et al
    The relationship between executive functions and fluid intelligence in multiple sclerosis.
    PLoS One. 2020;15:e0231868.
    PubMed     Abstract available


  200. VAN DE KREEKE JA, Darma S, Chan Pin Yin JMPL, Tan HS, et al
    The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy.
    PLoS One. 2020;15:e0231552.
    PubMed     Abstract available


  201. ABREGO-PEREDO A, Romero-Ramirez H, Espinosa E, Lopez-Herrera G, et al
    Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile.
    PLoS One. 2020;15:e0233138.
    PubMed     Abstract available


  202. HOLTE KB, Svanteson M, Hanssen KF, Sveen KA, et al
    Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study.
    PLoS One. 2020;15:e0233174.
    PubMed     Abstract available


  203. KIM SH, Rhee Y, Kim YM, Won YJ, et al
    Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study.
    PLoS One. 2020;15:e0232842.
    PubMed     Abstract available


  204. KATAOKA H, Ohara M, Suzuki T, Inoue T, et al
    Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
    PLoS One. 2020;15:e0232885.
    PubMed     Abstract available


  205. LUCCHETTA RC, Leonart LP, Goncalves MVM, Becker J, et al
    Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
    PLoS One. 2020;15:e0231722.
    PubMed     Abstract available


  206. BROWN FS, Glasmacher SA, Kearns PKA, MacDougall N, et al
    Systematic review of prediction models in relapsing remitting multiple sclerosis.
    PLoS One. 2020;15:e0233575.
    PubMed     Abstract available


  207. VAN JAD, Clotet-Freixas S, Hauschild AC, Batruch I, et al
    Urinary proteomics links keratan sulfate degradation and lysosomal enzymes to early type 1 diabetes.
    PLoS One. 2020;15:e0233639.
    PubMed     Abstract available


  208. SAKONO T, Meguro A, Takeuchi M, Yamane T, et al
    Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.
    PLoS One. 2020;15:e0233464.
    PubMed     Abstract available


  209. KUSNIEROVA P, Zeman D, Hradilek P, Zapletalova O, et al
    Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    PLoS One. 2020;15:e0233519.
    PubMed     Abstract available


  210. PAMPHLETT R, Mak R, Lee J, Buckland ME, et al
    Concentrations of toxic metals and essential trace elements vary among individual neurons in the human locus ceruleus.
    PLoS One. 2020;15:e0233300.
    PubMed     Abstract available


  211. IMAI E, Usui J, Kaneko S, Kawamura T, et al
    The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies.
    PLoS One. 2020;15:e0233186.
    PubMed     Abstract available


  212. GILLEY KN, Wierenga KA, Chauhuan PS, Wagner JG, et al
    Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice.
    PLoS One. 2020;15:e0233183.
    PubMed     Abstract available


  213. MURATA T, Kyozuka H, Fukuda T, Yasuda S, et al
    Risk of adverse obstetric outcomes in Japanese women with systemic lupus erythematosus: The Japan Environment and Children's Study.
    PLoS One. 2020;15:e0233883.
    PubMed     Abstract available


  214. BHATIA SM, Streilein RD, Hall RP
    Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
    PLoS One. 2020;15:e0233957.
    PubMed     Abstract available


  215. BAUER A, Lechner I, Auer M, Berger T, et al
    Influence of physical activity on serum vitamin D levels in people with multiple sclerosis.
    PLoS One. 2020;15:e0234333.
    PubMed     Abstract available


  216. MORKHOLT AS, Oklinski MK, Larsen A, Bockermann R, et al
    Pharmacological inhibition of carnitine palmitoyl transferase 1 inhibits and reverses experimental autoimmune encephalitis in rodents.
    PLoS One. 2020;15:e0234493.
    PubMed     Abstract available


  217. MORALES PANTOJA IE, Smith MD, Rajbhandari L, Cheng L, et al
    iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu.
    PLoS One. 2020;15:e0233980.
    PubMed     Abstract available


  218. VIAR K, Njoku D, Secor McVoy J, Oh U, et al
    Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
    PLoS One. 2020;15:e0235110.
    PubMed     Abstract available


  219. JI H, Godsland I, Oliver NS, Hill NE, et al
    Loss of association between HbA1c and vascular disease in older adults with type 1 diabetes.
    PLoS One. 2020;15:e0234319.
    PubMed     Abstract available


  220. KEMMERER CL, Pernpeintner V, Ruschil C, Abdelhak A, et al
    Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-beta, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
    PLoS One. 2020;15:e0235449.
    PubMed     Abstract available


  221. CHERAGHMAKANI H, Baghbanian SM, HabibiSaravi R, Azar A, et al
    Age and sex-adjusted incidence and yearly prevalence of multiple sclerosis (MS) in Mazandaran province, Iran: An 11-years study.
    PLoS One. 2020;15:e0235562.
    PubMed     Abstract available


  222. JIANG K, Kessler H, Park Y, Sudman M, et al
    Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci.
    PLoS One. 2020;15:e0235857.
    PubMed     Abstract available


  223. JEON HS, Lee SM, Jung YM, Oh S, et al
    Proteomic biomarkers in mid-trimester amniotic fluid associated with adverse pregnancy outcomes in patients with systemic lupus erythematosus.
    PLoS One. 2020;15:e0235838.
    PubMed     Abstract available


  224. VON BORSTEL A, Abdulahad WH, Dekkema G, Rutgers A, et al
    Mycophenolic acid and 6-mercaptopurine both inhibit B-cell proliferation in granulomatosis with polyangiitis patients, whereas only mycophenolic acid inhibits B-cell IL-6 production.
    PLoS One. 2020;15:e0235743.
    PubMed     Abstract available


  225. ROTSTEIN DL, Marrie RA, Tu K, Schultz SE, et al
    Health service utilization in immigrants with multiple sclerosis.
    PLoS One. 2020;15:e0234876.
    PubMed     Abstract available


  226. ILJICSOV A, Milanovich D, Ajtay A, Oberfrank F, et al
    Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data.
    PLoS One. 2020;15:e0236432.
    PubMed     Abstract available


  227. FARCI R, Carta A, Cocco E, Frau J, et al
    Optical coherence tomography angiography in multiple sclerosis: A cross-sectional study.
    PLoS One. 2020;15:e0236090.
    PubMed     Abstract available


  228. MALDINEY T, Greigert H, Martin L, Benoit E, et al
    Full-field optical coherence tomography for the diagnosis of giant cell arteritis.
    PLoS One. 2020;15:e0234165.
    PubMed     Abstract available


  229. ZHAI Y, Liu Y, Qi Y, Long X, et al
    The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy.
    PLoS One. 2020;15:e0234492.
    PubMed     Abstract available


  230. CAVERZASI E, Cordano C, Zhu AH, Zhao C, et al
    Imaging correlates of visual function in multiple sclerosis.
    PLoS One. 2020;15:e0235615.
    PubMed     Abstract available


  231. CHEN CH, Wu MJ, Wen MC, Tsai SF, et al
    Crescents formations are independently associated with higher mortality in biopsy-confirmed immunoglobulin A nephropathy.
    PLoS One. 2020;15:e0237075.
    PubMed     Abstract available


  232. MANION KP, Baglaenko Y, Chang NH, Talaei N, et al
    Impaired B cell anergy is not sufficient to breach tolerance to nuclear antigen in Vkappa8/3H9 lupus-prone mice.
    PLoS One. 2020;15:e0236664.
    PubMed     Abstract available


  233. MARCHINI GS, Cestari IN, Salemi VMC, Irigoyen MC, et al
    Early changes in myocyte contractility and cardiac function in streptozotocin-induced type 1 diabetes in rats.
    PLoS One. 2020;15:e0237305.
    PubMed     Abstract available


  234. BRIX N, Rosthoj S, Glerup M, Hasle H, et al
    Identifying acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis in children.
    PLoS One. 2020;15:e0237530.
    PubMed     Abstract available


  235. BYEON HJ, Kim JY, Ko J, Lee EJ, et al
    Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    PLoS One. 2020;15:e0237015.
    PubMed     Abstract available


  236. OPARA CN, Akintorin M, Byrd A, Cirignani N, et al
    Maternal diabetes mellitus as an independent risk factor for clinically significant retinopathy of prematurity severity in neonates less than 1500g.
    PLoS One. 2020;15:e0236639.
    PubMed     Abstract available


  237. COBO-CALVO A, Ruiz A, Richard C, Blondel S, et al
    Purified IgG from aquaporin-4 neuromyelitis optica spectrum disorder patients alters blood-brain barrier permeability.
    PLoS One. 2020;15:e0238301.
    PubMed     Abstract available


  238. SINHA S, Renavikar PS, Crawford MP, Steward-Tharp SM, et al
    Altered expression of SIRPgamma on the T-cells of relapsing remitting multiple sclerosis and type 1 diabetes patients could potentiate effector responses from T-cells.
    PLoS One. 2020;15:e0238070.
    PubMed     Abstract available


  239. ALTAMIRANO-BUSTAMANTE NF, Garrido-Magana E, Moran E, Calderon A, et al
    Protein-conformational diseases in childhood: Naturally-occurring hIAPP amyloid-oligomers and early beta-cell damage in obesity and diabetes.
    PLoS One. 2020;15:e0237667.
    PubMed     Abstract available


  240. REED JC, Preston-Hurlburt P, Philbrick W, Betancur G, et al
    The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling.
    PLoS One. 2020;15:e0236921.
    PubMed     Abstract available


  241. DEWAN K, Berke GS, Chhetri DK
    Lessons learned from open laryngotracheal airway resection and primary anastomosis in high risk patients.
    PLoS One. 2020;15:e0238426.
    PubMed     Abstract available


  242. SOUZA KM, Diniz IM, Lemos LLP, Junior NGR, et al
    Effectiveness of first-line treatment for relapsing-remitting multiple sclerosis in Brazil: A 16-year non-concurrent cohort study.
    PLoS One. 2020;15:e0238476.
    PubMed     Abstract available


  243. ZVIZDIC Z, Kovacevic A, Milisic E, Jonuzi A, et al
    Clinical course and short-term outcome of postsplenectomy reactive thrombocytosis in children without myeloproliferative disorders: A single institutional experience from a developing country.
    PLoS One. 2020;15:e0237016.
    PubMed     Abstract available


  244. CUBILLOS-ANGULO JM, Vinhaes CL, Fukutani ER, Albuquerque VVS, et al
    In silico transcriptional analysis of mRNA and miRNA reveals unique biosignatures that characterizes different types of diabetes.
    PLoS One. 2020;15:e0239061.
    PubMed     Abstract available


  245. RADWAN S, Gilfillan D, Eklund B, Radwan HM, et al
    A comparative study of the gut microbiome in Egyptian patients with Type I and Type II diabetes.
    PLoS One. 2020;15:e0238764.
    PubMed     Abstract available


  246. ALNAJASHI H, Jabbad R
    Behavioral practices of patients with multiple sclerosis during Covid-19 pandemic.
    PLoS One. 2020;15:e0241103.
    PubMed     Abstract available


  247. BEREK K, Hegen H, Auer M, Zinganell A, et al
    Cerebrospinal fluid oligoclonal bands in Neuroborreliosis are specific for Borrelia burgdorferi.
    PLoS One. 2020;15:e0239453.
    PubMed     Abstract available


  248. MOSER O, Mueller A, Eckstein ML, Ziko H, et al
    Improved glycaemic variability and basal insulin dose reduction during a running competition in recreationally active adults with type 1 diabetes-A single-centre, prospective, controlled observational study.
    PLoS One. 2020;15:e0239091.
    PubMed     Abstract available


  249. OSINSKI M, Mantaj U, Kedzia M, Gutaj P, et al
    Poor glycaemic control contributes to a shift towards prothrombotic and antifibrinolytic state in pregnant women with type 1 diabetes mellitus.
    PLoS One. 2020;15:e0237843.
    PubMed     Abstract available


  250. YOSHIDA M, Kondo K, Matsui N, Izumi Y, et al
    Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients.
    PLoS One. 2020;15:e0239756.
    PubMed     Abstract available


  251. POHLMANN D, Barth A, Macedo S, Pleyer U, et al
    The impact of impending / onset of vision loss on depression, anxiety, and vision-related quality of life in Birdshot-Retinochoroiditis and Serpiginous Choroiditis.
    PLoS One. 2020;15:e0239210.
    PubMed     Abstract available


  252. ONG JX, Kwan CC, Cicinelli MV, Fawzi AA, et al
    Superficial capillary perfusion on optical coherence tomography angiography differentiates moderate and severe nonproliferative diabetic retinopathy.
    PLoS One. 2020;15:e0240064.
    PubMed     Abstract available


  253. HUANG SK, Huang CY, Lin CH, Cheng BW, et al
    Acute kidney injury is a common complication in children and adolescents hospitalized for diabetic ketoacidosis.
    PLoS One. 2020;15:e0239160.
    PubMed     Abstract available


  254. VAIDYA A, Kakizaki H, Takahashi Y
    Changes in horizontal strabismus after inferior rectus muscle recession with or without nasal transposition in thyroid eye disease: A retrospective, observational study.
    PLoS One. 2020;15:e0240019.
    PubMed     Abstract available


  255. DHAOUADI T, Abdellatif J, Trabelsi R, Gaied H, et al
    PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
    PLoS One. 2020;15:e0240025.
    PubMed     Abstract available


  256. NEVES PDMM, Souza RA, Torres FM, Reis FA, et al
    Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.
    PLoS One. 2020;15:e0233199.
    PubMed     Abstract available


  257. MELNIKOV M, Sharanova S, Sviridova A, Rogovskii V, et al
    The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
    PLoS One. 2020;15:e0240305.
    PubMed     Abstract available


  258. D'ALMEIDA OC, Violante IR, Quendera B, Moreno C, et al
    The neurometabolic profiles of GABA and Glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes.
    PLoS One. 2020;15:e0240907.
    PubMed     Abstract available


  259. KUEHN JC, Meschede C, Helmstaedter C, Surges R, et al
    Adult-onset temporal lobe epilepsy suspicious for autoimmune pathogenesis: Autoantibody prevalence and clinical correlates.
    PLoS One. 2020;15:e0241289.
    PubMed     Abstract available


  260. PERLEJEWSKI K, Bukowska-Osko I, Rydzanicz M, Dzieciatkowski T, et al
    Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics.
    PLoS One. 2020;15:e0240601.
    PubMed     Abstract available


  261. LIU L, Wang R, Ding H, Tian L, et al
    The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
    PLoS One. 2020;15:e0240942.
    PubMed     Abstract available


  262. BORCHERT C, Herman A, Roth M, Brooks AC, et al
    RNA sequencing of whole blood in dogs with primary immune-mediated hemolytic anemia (IMHA) reveals novel insights into disease pathogenesis.
    PLoS One. 2020;15:e0240975.
    PubMed     Abstract available


  263. THOMSEN H, Li X, Sundquist K, Sundquist J, et al
    Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
    PLoS One. 2020;15:e0240794.
    PubMed     Abstract available


  264. COTTRELL L, Economos G, Evans C, Silber E, et al
    A realist review of advance care planning for people with multiple sclerosis and their families.
    PLoS One. 2020;15:e0240815.
    PubMed     Abstract available


  265. CHOI JY, Chin HJ, Lee H, Bae EH, et al
    Idiopathic membranous nephropathy in older patients: Clinical features and outcomes.
    PLoS One. 2020;15:e0240566.
    PubMed     Abstract available


  266. MOCHIZUKI M, Ito Y, Yokomichi H, Kikuchi T, et al
    Increasing secular trends in height and obesity in children with type 1 diabetes: JSGIT cohort.
    PLoS One. 2020;15:e0242259.
    PubMed     Abstract available


  267. GROHOVA A, Danova K, Adkins I, Sumnik Z, et al
    Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.
    PLoS One. 2020;15:e0242092.
    PubMed     Abstract available


  268. CORTEZ FJ, Gebhart D, Robinson PV, Seftel D, et al
    Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR.
    PLoS One. 2020;15:e0242049.
    PubMed     Abstract available


  269. ZHANG X, Gao B, Xu B
    No association between the vitamin D-binding protein (DBP) gene polymorphisms (rs7041 and rs4588) and multiple sclerosis and type 1 diabetes mellitus: A meta-analysis.
    PLoS One. 2020;15:e0242256.
    PubMed     Abstract available


  270. KASHIWAKURA JI, Saitoh K, Ihara T, Sasaki Y, et al
    Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells.
    PLoS One. 2020;15:e0241440.
    PubMed     Abstract available


  271. ABE K, Fujita M, Hayashi M, Takahashi A, et al
    Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.
    PLoS One. 2020;15:e0239481.
    PubMed     Abstract available


  272. AMADOU C, Denis P, Cosker K, Fagot-Campagna A, et al
    Less amputations for diabetic foot ulcer from 2008 to 2014, hospital management improved but substantial progress is still possible: A French nationwide study.
    PLoS One. 2020;15:e0242524.
    PubMed     Abstract available


  273. PERRAUDIN C, Bourdin A, Vicino A, Kuntzer T, et al
    Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis.
    PLoS One. 2020;15:e0242630.
    PubMed     Abstract available


  274. BASUALTO-ALARCON C, Urra FA, Bozan MF, Jana F, et al
    Idiopathic inflammatory myopathy human derived cells retain their ability to increase mitochondrial function.
    PLoS One. 2020;15:e0242443.
    PubMed     Abstract available


  275. MIGITA K, Nakamura M, Aiba Y, Kozuru H, et al
    Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
    PLoS One. 2020;15:e0238540.
    PubMed     Abstract available


  276. NIKOLIC B, Ivancevic N, Zaletel I, Rovcanin B, et al
    Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
    PLoS One. 2020;15:e0243031.
    PubMed     Abstract available


  277. DING M, Markon A, Wolpert B, Chavarro JE, et al
    Associations of body mass index and waist circumference with risk of Guillain-Barre syndrome in women and men: A prospective analysis of three cohort studies.
    PLoS One. 2020;15:e0239099.
    PubMed     Abstract available


  278. VICKARYOUS N, Jitlal M, Jacobs BM, Middleton R, et al
    Remote testing of vitamin D levels across the UK MS population-A case control study.
    PLoS One. 2020;15:e0241459.
    PubMed     Abstract available


  279. AFAA TJ, Amegan-Aho KH, Dono MT, Odei E, et al
    Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa.
    PLoS One. 2020;15:e0239964.
    PubMed     Abstract available


  280. SMAOUI MR, Rabasa-Lhoret R, Haidar A
    Development platform for artificial pancreas algorithms.
    PLoS One. 2020;15:e0243139.
    PubMed     Abstract available


  281. FREITAS DA, Souza-Santos R, Carvalho LMA, Barros WB, et al
    Congenital Zika syndrome: A systematic review.
    PLoS One. 2020;15:e0242367.
    PubMed     Abstract available


  282. CORDON B, Vilades E, Orduna E, Satue M, et al
    Angiography with optical coherence tomography as a biomarker in multiple sclerosis.
    PLoS One. 2020;15:e0243236.
    PubMed     Abstract available


  283. TANAKA H, Yamaguchi M, Katsuno T, Sugiyama H, et al
    Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.
    PLoS One. 2020;15:e0243572.
    PubMed     Abstract available


  284. ZOPPINI G, Bergamini C, Trombetta M, Mantovani A, et al
    Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes.
    PLoS One. 2020;15:e0244483.
    PubMed     Abstract available


    January 2019
  285. BURKILL S, Vattulainen P, Geissbuehler Y, Sabido Espin M, et al
    The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis.
    PLoS One. 2019;14:e0227120.
    PubMed     Abstract available


  286. PAN X, Kaminga AC, Wen SW, Acheampong K, et al
    Omentin-1 in diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226292.
    PubMed     Abstract available


  287. CORTINI A, Bembich S, Marson L, Cocco E, et al
    Identification of novel non-myelin biomarkers in multiple sclerosis using an improved phage-display approach.
    PLoS One. 2019;14:e0226162.
    PubMed     Abstract available


  288. HAMMAD SM, Hardin JR, Wilson DA, Twal WO, et al
    Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity.
    PLoS One. 2019;14:e0224496.
    PubMed     Abstract available


  289. CECCARELLI F, Pirone C, Mina C, Mascolo A, et al
    Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
    PLoS One. 2019;14:e0224437.
    PubMed     Abstract available


  290. POSTIGO-ALONSO B, Galvao-Carmona A, Conde-Gavilan C, Jover A, et al
    The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls.
    PLoS One. 2019;14:e0226775.
    PubMed     Abstract available


  291. MELIS M, Littera R, Cocco E, Frau J, et al
    Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis.
    PLoS One. 2019;14:e0226615.
    PubMed     Abstract available


  292. EHLING R, Amprosi M, Kremmel B, Bsteh G, et al
    Second language learning induces grey matter volume increase in people with multiple sclerosis.
    PLoS One. 2019;14:e0226525.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: